• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNF-α/ROS/HIF-1 诱导的 FoxMI 表达上调促进 HCC 增殖和抗细胞凋亡。

The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.

机构信息

State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Fourth Military Medical University Xi'an 710032, Shaanxi Province, People's Republic of China.

出版信息

Carcinogenesis. 2012 Nov;33(11):2250-9. doi: 10.1093/carcin/bgs249. Epub 2012 Jul 25.

DOI:10.1093/carcin/bgs249
PMID:22831955
Abstract

The proliferation-specific transcription factor Forkhead box M1 (FoxM1) acts as a master regulator of cancer cell growth and survival and plays an important role in the development of hepatocellular carcinoma. However, the molecular mechanisms that regulate FoxM1 expression remain largely unknown. In the current study, we demonstrated that tumor necrosis factor (TNF)-αα induced FoxM1 expression and transactivated its promoter activity in hepatoma cells. Serial 5" deletion and site-directed mutagenesis revealed that the induction of FoxM1 expression by TNF-α was dependent upon the hypoxia-inducible factor 1 (HIF1)-1 and HIF1-3/4 binding sites within the FoxM1 promoter. Furthermore, at the transcriptional level, the stabilization of HIF-1α via reactive oxygen species generation led to the binding of HIF-1α to the FoxM1 promoter and resulted in increased FoxM1 expression. The inhibition of both HIF-1α expression and reactive oxygen species generation significantly decreased TNF-α-induced FoxM1 overexpression. Consequently, the upregulation of FoxM1 promoted the proliferation of hepatoma cells and enhanced their resistance to TNF-α-induced apoptosis. Consistently, there was a positive correlation between HIF-1α and FoxM1 expression in 406 human hepatocellular carcinoma tissues, and the combination of these two parameters was a powerful predictor of poor prognosis in hepatocellular carcinoma patients after curative resection. Here, we report a new molecular mechanism by which FoxM1 expression is regulated by the TNF-α/reactive oxygen species/HIF-1 pathway, and this mechanism results in the proliferation of hepatoma cells and their resistance to apoptosis.

摘要

增殖特异性转录因子叉头盒 M1(FoxM1)作为癌细胞生长和存活的主调控因子,在肝细胞癌的发生发展中发挥着重要作用。然而,调节 FoxM1 表达的分子机制在很大程度上仍然未知。在本研究中,我们证明肿瘤坏死因子(TNF)-α诱导肝癌细胞中 FoxM1 的表达并反式激活其启动子活性。连续 5'缺失和定点突变显示,TNF-α诱导 FoxM1 表达依赖于 FoxM1 启动子内的缺氧诱导因子 1(HIF1)-1 和 HIF1-3/4 结合位点。此外,在转录水平上,通过活性氧生成稳定 HIF-1α,导致 HIF-1α与 FoxM1 启动子结合,从而增加 FoxM1 表达。抑制 HIF-1α 的表达和活性氧的生成显著减少 TNF-α诱导的 FoxM1 过表达。因此,FoxM1 的上调促进了肝癌细胞的增殖,并增强了它们对 TNF-α诱导的凋亡的抵抗。一致地,在 406 个人肝癌组织中观察到 HIF-1α和 FoxM1 表达之间存在正相关,并且这两个参数的组合是肝癌患者根治性切除术后预后不良的有力预测因子。在这里,我们报告了 FoxM1 表达受 TNF-α/活性氧/HIF-1 通路调节的新分子机制,该机制导致肝癌细胞的增殖及其对凋亡的抵抗。

相似文献

1
The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.TNF-α/ROS/HIF-1 诱导的 FoxMI 表达上调促进 HCC 增殖和抗细胞凋亡。
Carcinogenesis. 2012 Nov;33(11):2250-9. doi: 10.1093/carcin/bgs249. Epub 2012 Jul 25.
2
Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma.p53 负调控转录因子 FoxM1 增强肝癌细胞对奥沙利铂诱导的衰老。
Cancer Lett. 2013 Apr 30;331(1):105-14. doi: 10.1016/j.canlet.2012.12.008. Epub 2012 Dec 20.
3
FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.FoxM1过表达促进肝细胞癌的上皮-间质转化和转移。
World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.
4
Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒 X 蛋白上调 FoxM1 表达促进肿瘤转移,并预示乙型肝炎病毒相关性肝细胞癌的不良预后。
J Hepatol. 2012 Sep;57(3):600-12. doi: 10.1016/j.jhep.2012.04.020. Epub 2012 May 18.
5
Transcriptional up-regulation of FoxM1 in response to hypoxia is mediated by HIF-1.缺氧反应中FoxM1的转录上调由HIF-1介导。
J Cell Biochem. 2009 Feb 1;106(2):247-56. doi: 10.1002/jcb.21996.
6
MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.微小RNA-338-3p通过靶向缺氧诱导因子1α抑制肝癌细胞并使这些细胞对索拉非尼敏感。
PLoS One. 2014 Dec 22;9(12):e115565. doi: 10.1371/journal.pone.0115565. eCollection 2014.
7
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.缺氧通过缺氧诱导因子-2α上调人肝癌细胞中的丝氨酸蛋白酶抑制剂B3。
Oncotarget. 2015 Feb 10;6(4):2206-21. doi: 10.18632/oncotarget.2943.
8
TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.触发受体表达分子-1(TREM-1)作为一种炎症调节因子,在肝癌细胞中表达,并显著促进肿瘤进展。
Ann Surg Oncol. 2015 Sep;22(9):3121-9. doi: 10.1245/s10434-014-4191-7. Epub 2014 Dec 3.
9
Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients.FOXF2表达缺失预示肝细胞癌患者预后不良。
Ann Surg Oncol. 2016 Jan;23(1):211-7. doi: 10.1245/s10434-015-4515-2. Epub 2015 Mar 31.
10
LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.LXRα 介导的 FOXM1 下调抑制肝癌细胞的增殖。
Oncogene. 2014 May 29;33(22):2888-97. doi: 10.1038/onc.2013.250. Epub 2013 Jul 1.

引用本文的文献

1
Deciphering hypoxia's role in hepatocellular carcinoma prognosis with single-cell approaches.利用单细胞方法解读缺氧在肝细胞癌预后中的作用。
Discov Oncol. 2025 Jul 26;16(1):1411. doi: 10.1007/s12672-025-03201-y.
2
Deuterium-depleted water inhibits the malignant progression of colorectal cancer cells by modulating oxidative stress.低氘水通过调节氧化应激来抑制结肠癌细胞的恶性进展。
Oncol Rep. 2025 Jun;53(6). doi: 10.3892/or.2025.8903. Epub 2025 May 2.
3
The oncogenic role of FOXM1 in hepatocellular carcinoma: molecular mechanisms, clinical significance, and therapeutic potentials.
FOXM1在肝细胞癌中的致癌作用:分子机制、临床意义及治疗潜力
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 23. doi: 10.1007/s00210-025-04144-5.
4
TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization.TP53突变预示经动脉栓塞治疗的肝细胞癌患者生存期更差且局部进展更早。
Curr Oncol. 2025 Jan 18;32(1):51. doi: 10.3390/curroncol32010051.
5
Development of hepatocellular carcinoma organoid model recapitulating HIF-1A metabolic signature.开发重现 HIF-1A 代谢特征的肝癌类器官模型。
Clin Exp Med. 2024 Nov 21;25(1):9. doi: 10.1007/s10238-024-01521-x.
6
GTSE1 promotes nasopharyngeal carcinoma proliferation and angiogenesis by upregulating STMN1.GTSE1通过上调STMN1促进鼻咽癌增殖和血管生成。
Cell Div. 2024 May 2;19(1):16. doi: 10.1186/s13008-024-00119-9.
7
Identification of EGR4 as a prospective target for inhibiting tumor cell proliferation and a novel biomarker in colorectal cancer.鉴定 EGR4 为抑制肿瘤细胞增殖的潜在靶点和结直肠癌的新型生物标志物。
Cancer Gene Ther. 2024 Jun;31(6):871-883. doi: 10.1038/s41417-024-00743-1. Epub 2024 Mar 8.
8
The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment.FOXM1抑制剂联合疗法在癌症治疗中的前景
Cancers (Basel). 2024 Feb 12;16(4):756. doi: 10.3390/cancers16040756.
9
Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma.FOXM1 因子在肝细胞癌中的全面临床病理意义及潜在转录机制。
World J Surg Oncol. 2023 Nov 25;21(1):366. doi: 10.1186/s12957-023-03250-z.
10
The Antitumor Potential of λ-Carrageenan Oligosaccharides on Gastric Carcinoma by Immunomodulation.λ-卡拉胶寡糖通过免疫调节抑制胃癌的抗肿瘤潜力。
Nutrients. 2023 Apr 24;15(9):2044. doi: 10.3390/nu15092044.